Aurora Diagnostics. Illuminating the Path to Better Health
Learn More

Investor Relations

  

SEC Filings

Form 10-Q for Q3-2011 - PDF    XBRL Files


Access to Financial Information Released Prior to November 4, 2011

Prior to November 4, 2011, Aurora Diagnostics restricted access to its financial information. Current or prospective holders of the Company's 10.750% Senior Notes due 2018, as well as securities analysts, are eligible to obtain access to a secure Website to which the company has posted certain reports and press releases required by the indentures governing the Notes.

To apply for access to the secure Website, please complete and submit the Financial Information Request Application below. Upon receipt of your application, we will send you a link to the secured Website. By submitting this application and receiving access to the company's confidential information, you agree to keep such information confidential and not to publish, distribute or post such information without the company's permission. By submitting this application, you also agree that the company reserves the right to modify the terms of your access to the secure Website or future conference calls at any time and without notice.

Financial Information Request Application

 

For questions and inquiries regarding the foregoing, please contact:

Gregory A. Marsh
Vice President and Chief Financial Officer | Investor Relations Contact
gmarsh@auroradx.com.